Gene: MLLT1
Official Full Name: MLLT1 super elongation complex subunitprovided by HGNC
Gene Summary: Predicted to enable chromatin binding activity and lysine-acetylated histone binding activity. Predicted to be involved in positive regulation of DNA-templated transcription. Predicted to act upstream of or within negative regulation of protein kinase activity. Located in cytosol; fibrillar center; and nucleoplasm. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06358 | MLLT1 Knockout cell line (HeLa) | Human | MLLT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06359 | MLLT1 Knockout cell line (HCT 116) | Human | MLLT1 | 1:2~1:4 | Negative | Online Inquiry |
KO06360 | MLLT1 Knockout cell line (HEK293) | Human | MLLT1 | 1:3~1:6 | Negative | Online Inquiry |
KO06361 | MLLT1 Knockout cell line (A549) | Human | MLLT1 | 1:3~1:4 | Negative | Online Inquiry |
MLLT1 Gene Knockout Cell Lines are genetically modified cell lines that have been specifically created to disrupt the expression of the MLLT1 gene, which plays a pivotal role in numerous biological processes and has implications in various diseases, particularly in cancer biology. These engineered cell lines serve as powerful tools for studying the functional role of MLLT1 in cellular pathways and its influence on phenomena such as proliferation, differentiation, and apoptosis.
The key function of the MLLT1 Gene Knockout Cell Lines centers around their ability to mimic the loss-of-function scenarios of the MLLT1 gene product in vitro. By utilizing CRISPR-Cas9 or other gene editing technologies, MLLT1 expression is effectively silenced, enabling researchers to investigate the resulting phenotypic changes and altered signaling pathways. This approach provides insights into how loss of MLLT1 may contribute to oncogenesis and tumor progression, facilitating the development of targeted therapies.
Scientifically, MLLT1 knockouts are crucial for elucidating the gene's roles in transcriptional regulation and chromatin dynamics, making them invaluable in basic research settings as well as translational research aimed at identifying novel therapeutic interventions. Furthermore, these cell lines can be utilized in drug discovery processes to screen for efficacy against tumor cells that exhibit altered gene expression profiles characteristic of MLLT1-induced malignancies.
Compared to traditional cell lines, which may retain the MLLT1 gene's functionalities, the MLLT1 Gene Knockout Cell Lines offer a unique advantage by providing a controlled environment to explore specific gene functions. This specificity enables clearer interpretations of experimental data, thereby enhancing reproducibility and precision in research findings.
For researchers and clinicians focused on cancer biology, genetics, or therapeutic development, the MLLT1 Gene Knockout Cell Lines represent a valuable addition to their investigative arsenal. By enabling focused studies on gene function and interaction, they help unlock new avenues in understanding disease mechanisms and fostering innovation in treatment.
Our company prides itself on delivering high-quality biological products backed by extensive research expertise and innovation. We are committed to advancing scientific understanding and providing tools that empower researchers to propel breakthroughs in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.